Sumitomo Pharma Co., Ltd.
R&D pharma creating medicines for oncology, psychiatry & neurology, focusing on Japan & the US.
4506 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 大阪市中央区道修町２丁目６番８号
- Website:
- https://www.sumitomo-pharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sumitomo Pharma Co., Ltd. is a research and development-oriented pharmaceutical company focused on creating innovative medicines and healthcare solutions. The company concentrates its R&D and commercial activities in the therapeutic areas of oncology, psychiatry, and neurology. It develops treatments across various modalities, including small molecules, regenerative medicine, and cell therapy. Sumitomo Pharma operates with global business platforms, with a strategic focus on Japan and the United States as its primary markets. The company's mission is to contribute to the betterment of healthcare and fuller lives for people worldwide by translating scientific innovation into real-world solutions.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Sumitomo Pharma Co., Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 09:05 |
Regulatory News Service
臨時報告書
|
Japanese | 29.6 KB | |
| 2025-06-26 09:39 |
Registration Form
確認書
|
Japanese | 8.7 KB | |
| 2025-06-26 09:36 |
Governance Information
内部統制報告書－第205期(2024/04/01－2025/03/31)
|
Japanese | 24.0 KB | |
| 2025-06-26 09:31 |
Annual Report
有価証券報告書－第205期(2024/04/01－2025/03/31)
|
Japanese | 2.1 MB | |
| 2025-05-30 09:41 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 40.7 KB | |
| 2025-05-14 09:18 |
M&A Activity
訂正臨時報告書
|
Japanese | 36.6 KB | |
| 2025-04-28 10:06 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 24.3 KB | |
| 2025-04-28 10:03 |
Regulatory News Service
臨時報告書
|
Japanese | 19.0 KB | |
| 2025-04-03 09:39 |
Regulatory News Service
臨時報告書
|
Japanese | 41.7 KB | |
| 2025-01-31 08:11 |
Regulatory News Service
臨時報告書
|
Japanese | 18.7 KB | |
| 2024-12-19 07:19 |
Regulatory News Service
臨時報告書
|
Japanese | 19.2 KB | |
| 2024-11-01 03:30 |
Interim Report
確認書
|
Japanese | 8.7 KB | |
| 2024-11-01 03:26 |
Interim Report
半期報告書－第205期(2024/04/01－2025/03/31)
|
Japanese | 334.4 KB | |
| 2024-10-30 07:42 |
Regulatory News Service
臨時報告書
|
Japanese | 18.6 KB | |
| 2024-07-31 08:40 |
Regulatory News Service
臨時報告書
|
Japanese | 18.7 KB |
Automate Your Workflow. Get a real-time feed of all Sumitomo Pharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Sumitomo Pharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
